Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke

Renée J. Turner1, Frank R. Sharp2
1Discipline of Anatomy and Pathology, Adelaide Centre for Neuroscience Research, School of Medicine, The University of Adelaide, Adelaide, SA, Australia
2Department of Neurology, MIND Institute, University of California at Davis Medical Center, Sacramento, CA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adibhatla, 2008, Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies, CNS Neurol. Disord. Drug Targets, 7, 243, 10.2174/187152708784936608

Agrawal, 2008, MMPs in the central nervous system: where the good guys go bad, Semin. Cell Dev. Biol., 19, 42, 10.1016/j.semcdb.2007.06.003

Alcaide, 2009, Neutrophil recruitment under shear flow: it's all about endothelial cell rings and gaps, Microcirculation, 16, 43, 10.1080/10739680802273892

Amantea, 2014, Early reperfusion injury is associated to MMP2 and IL-1beta elevation in cortical neurons of rats subjected to middle cerebral artery occlusion, Neuroscience, 277, 755, 10.1016/j.neuroscience.2014.07.064

Amantea, 2008, Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion, Neuroscience, 152, 8, 10.1016/j.neuroscience.2007.12.030

Anthony, 1997, Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke, Neuropathol. Appl. Neurobiol., 23, 406, 10.1111/j.1365-2990.1997.tb01315.x

Asahi, 2000, Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats, J. Cereb. Blood Flow Metab., 20, 452, 10.1097/00004647-200003000-00002

Asahi, 2001a, Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia, Neuroreport, 12, 3003, 10.1097/00001756-200109170-00050

Asahi, 2001b, Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia, J. Neurosci., 21, 7724, 10.1523/JNEUROSCI.21-19-07724.2001

Bajor, 2013, Proteolytic remodeling of the synaptic cell adhesion molecules (CAMs) by metzincins in synaptic plasticity, Neurochem. Res., 38, 1113, 10.1007/s11064-012-0919-6

Bakowski, 1992, Migration of polymorphonuclear leukocytes through human amnion membrane–a scanning electron microscopic study, Biol. Chem. Hoppe Seyler, 373, 529

Bauer, 2010, Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement, J. Cereb. Blood Flow Metab., 30, 837, 10.1038/jcbfm.2009.248

Benarroch, 2007, Tissue plasminogen activator: beyond thrombolysis, Neurology, 69, 799, 10.1212/01.wnl.0000269668.08747.78

Burk, 2008, Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice, Brain Res., 1226, 248, 10.1016/j.brainres.2008.06.015

Candelario-Jalil, 2009, Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia, Neuroscience, 158, 983, 10.1016/j.neuroscience.2008.06.025

Carbone, 2015, Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways, Vascul. Pharmacol., 64, 16, 10.1016/j.vph.2014.11.007

Castellanos, 2003, Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke, Stroke, 34, 40, 10.1161/01.STR.0000046764.57344.31

Castellanos, 2007, Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study, Stroke, 38, 1855, 10.1161/STROKEAHA.106.481556

Chang, 2003, Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia, J. Cereb. Blood Flow Metab., 23, 1408, 10.1097/01.WCB.0000091765.61714.30

Chesler, 1995, Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1, Blood, 86, 4506, 10.1182/blood.V86.12.4506.bloodjournal86124506

Choi, 2009, Mechanisms of neutrophil transendothelial migration, Front. Biosci., 14, 1596, 10.2741/3327

Clark, 1997, Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia, Neurosci. Lett., 238, 53, 10.1016/S0304-3940(97)00859-8

Clark, 2008, The regulation of matrix metalloproteinases and their inhibitors, Int. J. Biochem. Cell Biol., 40, 1362, 10.1016/j.biocel.2007.12.006

Conant, 2015, Activity dependent CAM cleavage and neurotransmission, Front. Cell. Neurosci., 9, 10.3389/fncel.2015.00305

Copin, 2005, Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice, Eur. J. Neurosci., 22, 1597, 10.1111/j.1460-9568.2005.04367.x

Cuadrado, 2008, Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release, J. Leukoc. Biol., 84, 207, 10.1189/jlb.0907606

Cuadrado, 2009, Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia, J. Cereb. Blood Flow Metab., 29, 398, 10.1038/jcbfm.2008.130

Cunningham, 2005, Multiple roles for MMPs and TIMPs in cerebral ischemia, Glia, 50, 329, 10.1002/glia.20169

Dejonckheere, 2011, Matrix metalloproteinases as drug targets in ischemia/reperfusion injury, Drug Discov. Today, 16, 762, 10.1016/j.drudis.2011.06.009

Fanjul-Fernández, 2010, Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models, Biochim. Biophys. Acta, 1803, 3, 10.1016/j.bbamcr.2009.07.004

Fernandez-Patron, 2001, Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32], FASEB J., 15, 2230, 10.1096/fj.01-0178com

Ferry, 1997, Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury, FEBS Lett., 402, 111, 10.1016/S0014-5793(96)01508-6

Fiorelli, 1999, Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort, Strok, 30, 2280, 10.1161/01.STR.30.11.2280

Fujimoto, 2008, Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia, J. Cereb. Blood Flow Metab., 28, 1674, 10.1038/jcbfm.2008.59

Fujimura, 1999, Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion, Brain Res., 842, 92, 10.1016/S0006-8993(99)01843-0

Fujimura, 2009, Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease, Surg. Neurol., 72, 476, 10.1016/j.surneu.2008.10.009

Gasche, 2001, Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia, J. Cereb. Blood Flow Metab., 21, 1393, 10.1097/00004647-200112000-00003

Gasche, 1999, Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction, J. Cereb. Blood Flow Metab., 19, 1020, 10.1097/00004647-199909000-00010

Gasche, 2006, Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain, Front. Biosci., 11, 1289, 10.2741/1883

Gautier, 2009, Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia, Br. J. Pharmacol., 156, 673, 10.1111/j.1476-5381.2009.00068.x

Gidday, 2005, Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia, Am. J. Physiol. Heart Circ. Physiol., 289, H558, 10.1152/ajpheart.01275.2004

Golab, 2014, The rtPA increases MMP-9 activity in serum during ischaemic stroke, Neurol. Neurochir. Pol., 48, 309, 10.1016/j.pjnns.2014.07.012

Gu, 2002, S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death, Science, 297, 1186, 10.1126/science.1073634

Gurney, 2006, Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation, Neurobiol. Dis., 23, 87, 10.1016/j.nbd.2006.02.006

Gürsoy-Ozdemir, 2000, Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia, Stroke, 31, 1974, 10.1161/01.STR.31.8.1974

Hacke, 1996, ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs, Arch. Neurol., 53, 309, 10.1001/archneur.1996.00550040037012

Harris, 2005, Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke, BMC Neurosci., 6, 49, 10.1186/1471-2202-6-49

Heo, 2003, Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure, Stroken, 34, e48, 10.1161/01.str.0000073788.81170.1c

Heo, 1999, Matrix metalloproteinases increase very early during experimental focal cerebral ischemia, J. Cereb. Blood Flow Metab., 19, 624, 10.1097/00004647-199906000-00005

Horstmann, 2003, Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies, Stroken, 34, 2165, 10.1161/01.STR.0000088062.86084.F2

Hu, 2009, Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model, Exp. Neurol., 216, 35, 10.1016/j.expneurol.2008.11.007

Inzitari, 2013, MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death, Stroke, 44, 2901, 10.1161/STROKEAHA.113.002274

Jickling, 2014, Hemorrhagic transformation after ischemic stroke in animals and humans, J. Cereb. Blood Flow Metab., 34, 185, 10.1038/jcbfm.2013.203

Justicia, 2003, Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats, J. Cereb. Blood Flow Metab., 23, 1430, 10.1097/01.WCB.0000090680.07515.C8

Keck, 2002, Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat, Gastroenterology, 122, 188, 10.1053/gast.2002.30348

Kelly, 2006, Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis, Exp. Neurol., 200, 38, 10.1016/j.expneurol.2006.01.032

Khandoga, 2006, Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver, J. Leukoc. Biol., 79, 1295, 10.1189/jlb.0805468

Kim, 2005, Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia, J. Neurosci., 25, 3701, 10.1523/JNEUROSCI.4346-04.2005

Kuroiwa, 1985, Role of extracellular proteins in the dynamics of vasogenic brain edema, Acta Neuropathol., 66, 3, 10.1007/BF00698288

Kurzepa, 2006, Simvastatin could prevent increase of the serum MMP-9/TIMP-1 ratio in acute ischaemic stroke, Folia Biol., 52, 181

Lapchak, 2000, Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke, Stroke, 31, 3034, 10.1161/01.STR.31.12.3034

Lee, 2003, Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma, J. Allergy Clin. Immunol., 111, 1278, 10.1067/mai.2003.1501

Lenglet, 2015, Role of matrix metalloproteinases in animal models of ischemic stroke, Curr. Vasc. Pharmacol., 13, 161, 10.2174/15701611113116660161

Lenglet, 2014, Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke, Thromb. Haemost., 112, 363, 10.1160/TH14-01-0007

Li, 2013, The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats, Neurosci. Lett., 550, 168, 10.1016/j.neulet.2013.06.034

Lucivero, 2007, Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke, Neurol. Sci., 28, 165, 10.1007/s10072-007-0814-0

Lukes, 1999, Extracellular matrix degradation by metalloproteinases and central nervous system diseases, Mol. Neurobiol., 19, 267, 10.1007/BF02821717

Lynch, 2004, Novel diagnostic test for acute stroke, Stroke, 35, 57, 10.1161/01.STR.0000105927.62344.4C

Machado, 2009, Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential, Stroke, 40, 3028, 10.1161/STROKEAHA.109.556852

Maier, 2004, Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia, Stroke, 35, 1169, 10.1161/01.STR.0000125861.55804.f2

Manabe, 2005, Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death, Invest. Ophthalmol. Vis. Sci., 46, 4747, 10.1167/iovs.05-0128

McCarthy, 2008, Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch, Biochemistry, 47, 5832, 10.1021/bi702496v

Moldes, 2008, High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA, Stroke, 39, 2006, 10.1161/STROKEAHA.107.495044

Montaner, 2001a, [Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke], Rev. Neurol., 33, 115

Montaner, 2001b, Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment, Stroke, 32, 1759, 10.1161/01.STR.32.8.1759

Montaner, 2001c, Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke, Stroke, 32, 2762, 10.1161/hs1201.99512

Montaner, 2003a, Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene, Stroke, 34, 2851, 10.1161/01.STR.0000098648.54429.1C

Montaner, 2003b, Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke, Circulation, 107, 598, 10.1161/01.CIR.0000046451.38849.90

Montaner, 2008, Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers, Stroken, 39, 2280, 10.1161/STROKEAHA.107.505354

Mun-Bryce, 1998, Matrix metalloproteinases in cerebrovascular disease, J. Cereb. Blood Flow Metab., 18, 1163, 10.1097/00004647-199811000-00001

Murata, 2008, Extension of the thrombolytic time window with minocycline in experimental stroke, Stroke, 39, 3372, 10.1161/STROKEAHA.108.514026

Nguyen, 2007, Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha, J. Neurochem., 102, 900, 10.1111/j.1471-4159.2007.04643.x

Ning, 2006, Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke, Neurology, 66, 1550, 10.1212/01.wnl.0000216133.98416.b4

Oda, 1995, Inhibition of neutrophil migration by a selective inhibitor of matrix metalloproteinase: analysis by intravital microscopy, Mediators Inflamm., 4, 133, 10.1155/S0962935195000238

Opdenakker, 2001, Gelatinase B functions as regulator and effector in leukocyte biology, J. Leukoc. Biol., 69, 851, 10.1189/jlb.69.6.851

Orbe, 2011, Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism, Circulation, 124, 2909, 10.1161/CIRCULATIONAHA.111.047100

Piccardi, 2015, Unbalanced metalloproteinase-9 and tissue inhibitors of metalloproteinases ratios predict hemorrhagic transformation of lesion in ischemic stroke patients treated with thrombolysis: results from the MAGIC study, Front. Neurol., 6, 10.3389/fneur.2015.00121

Planas, 2001, Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia, Neurobiol. Dis., 8, 834, 10.1006/nbdi.2001.0435

Ra, 2007, Control of matrix metalloproteinase catalytic activity, Matrix Biol., 26, 587, 10.1016/j.matbio.2007.07.001

Ramos-Fernandez, 2011, Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review, J. Stroke Cerebrovasc. Dis., 20, 47, 10.1016/j.jstrokecerebrovasdis.2009.10.008

Ranasinghe, 2012, Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor, Dev. Neurosci., 34, 417, 10.1159/000343257

Reynolds, 2003, Early biomarkers of stroke, Clin. Chem., 49, 1733, 10.1373/49.10.1733

Rivera, 2002, Gelatinase, B., and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, Eur. J. Neurosci., 15, 19, 10.1046/j.0953-816x.2001.01838.x

Rodríguez, 2013, proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke, J. Thromb. Haemost., 11, 1464, 10.1111/jth.12312

Rodrigues, 2015, Blood cells and endothelial barrier function, Tissue Barriers, 3, e978720, 10.4161/21688370.2014.978720

Rodríguez-Yáñez, 2006, New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke, Neurology, 67, 1973, 10.1212/01.wnl.0000247064.53130.91

Romanic, 1998, Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size, Stroke, 29, 1020, 10.1161/01.STR.29.5.1020

Rosell, 2005, A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke, Stroke, 36, 1415, 10.1161/01.STR.0000170641.01047.cc

Rosell, 2008, MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke, Stroke, 39, 1121, 10.1161/STROKEAHA.107.500868

Rosell, 2006, Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke, Stroke, 37, 1399, 10.1161/01.STR.0000223001.06264.af

Rosenberg, 2002, Matrix metalloproteinases in neuroinflammation, Glia, 39, 279, 10.1002/glia.10108

Rosenberg, 2001, Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures, Brain Res., 893, 104, 10.1016/S0006-8993(00)03294-7

Rosenberg, 1998, Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain, Stroke, 29, 2189, 10.1161/01.STR.29.10.2189

Rosenberg, 2007, Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia, Neurosurg. Focus, 22, E4, 10.3171/foc.2007.22.5.5

Sandoval, 2008, Blood-brain barrier tight junction permeability and ischemic stroke, Neurobiol. Dis., 32, 200, 10.1016/j.nbd.2008.08.005

Schnoor, 2008, Disassembly of endothelial and epithelial junctions during leukocyte transmigration, Front. Biosci., 13, 6638, 10.2741/3178

Shigemori, 2006, Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats, Acta Neurochir. Suppl., 96, 130, 10.1007/3-211-30714-1_29

Si-Tayeb, 2006, Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis, Am. J. Pathol., 169, 1390, 10.2353/ajpath.2006.060005

Sotgiu, 2006, Inflammatory biomarkers in blood of patients with acute brain ischemia, Eur. J. Neurol., 13, 505, 10.1111/j.1468-1331.2006.01280.x

Steadman, 1997, Human neutrophils do not degrade major basement membrane components during chemotactic migration, Int. J. Biochem. Cell Biol., 29, 993, 10.1016/S1357-2725(97)00038-1

Sternlicht, 2001, How matrix metalloproteinases regulate cell behavior, Annu. Rev. Cell Dev. Biol., 17, 463, 10.1146/annurev.cellbio.17.1.463

Sumii, 2002, Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats, Stroke, 33, 831, 10.1161/hs0302.104542

Svedin, 2007, Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia, J. Neurosci., 27, 1511, 10.1523/JNEUROSCI.4391-06.2007

Tan, 2003, Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons, Mol. Cell. Neurosci., 22, 98, 10.1016/S1044-7431(02)00024-6

Tang, 2006, Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study, J. Cereb. Blood Flow Metab., 26, 1089, 10.1038/sj.jcbfm.9600264

Tsuji, 2005, Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia, Stroke, 36, 1954, 10.1161/01.STR.0000177517.01203.eb

Tsuruoka, 2014, Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase, J. Stroke Cerebrovasc. Dis., 23, 2894, 10.1016/j.jstrokecerebrovasdis.2014.07.022

Turba, 2007, Recruited leukocytes and local synthesis account for increased matrix metalloproteinase-9 activity in cerebrospinal fluid of dogs with central nervous system neoplasm, J. Neurooncol., 81, 123, 10.1007/s11060-006-9213-2

Van den Steen, 2002, Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9), Crit. Rev. Biochem. Mol. Biol., 37, 375, 10.1080/10409230290771546

Vandooren, 2013, Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade, Crit. Rev. Biochem. Mol. Biol., 48, 222, 10.3109/10409238.2013.770819

Vukasovic, 2006, Matrix metalloproteinases and their inhibitors in different acute stroke subtypes, Clin. Chem. Lab. Med., 44, 428, 10.1515/cclm.2006.079

Wang, 2009, Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats, J. Cereb. Blood Flow Metab., 29, 1683, 10.1038/jcbfm.2009.87

Wang, 2002, The signaling pathways induced by neutrophil-endothelial cell adhesion, Antioxid. Redox Signal., 4, 39, 10.1089/152308602753625843

Wang, 2003, Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator, Nat. Med., 9, 1313, 10.1038/nm926

Yan, 2007, Regulation of matrix metalloproteinase gene expression, J. Cell. Physiol., 211, 19, 10.1002/jcp.20948

Yang, 2007, Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat, J. Cereb. Blood Flow Metab., 27, 697, 10.1515/CCLM.2006.079

Yang, 2011, Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-alpha/TACE in focal cerebral ischemia in mice, J. Neuroinflammation, 8, 108, 10.1186/1742-2094-8-108

Yushchenko, 2000, Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count, J. Neuroimmunol., 110, 244, 10.1016/S0165-5728(00)00339-8

Zhao, 2007, Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke, Stroke, 38, 748, 10.1161/01.STR.0000253500.32979.d1

Zhao, 2006, Role of matrix metalloproteinases in delayed cortical responses after stroke, Nat. Med., 12, 441, 10.1038/nm1387

Zhao, 2013, Effect of focal mild hypothermia on expression of MMP-9, TIMP-1, Tau-1 and beta-APP in rats with cerebral ischaemia/reperfusion injury, Brain Inj., 27, 1190, 10.3109/02699052.2013.804206

Zozulya, 2008, Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro, Brain Res., 1189, 1, 10.1016/j.brainres.2007.10.099